Advanced radiation for gynecologic cancer
Part of Injuries & trauma clinical trials.
This trial is for people with gynecologic cancer who will receive modern, targeted radiation therapy. It aims to see how well these advanced treatments work and how patients feel during and after therapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 90 years old.
- You have a gynecologic cancer (e.g., cervix, ovary, uterus, vaginal, or vulvar cancer).
- You are scheduled to receive advanced forms of radiation therapy, such as IGRT, IMRT, or SBRT.
- You do not have any other type of cancer besides a gynecologic cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether stereotactic (high-precision) radiation given in a few sessions can control rare cancers that have spread to a small number of sites. It aims to help by treating all known spots while keeping side effects manageable.
This trial tests advanced radiotherapy techniques in men with prostate cancer to see how well they work. If you are over 18 and have prostate cancer, this study might be an option for you.
This trial tests a personalized radiation therapy approach for gynecological tumors. It aims to improve treatment by adapting the radiation plan based on changes in the tumor and nearby organs during your therapy course.
This study tests new real-time image-guided radiation therapy methods for people getting curative radiation for certain cancers (brain, breast, head and neck, kidney, liver, lung, pancreas, prostate, or spine). It aims to see if these advanced imaging techniques work safely and effectively during treatment.
This trial tests combining two types of radiation therapy with an immunotherapy drug for people with advanced solid tumors that have spread or come back. The goal is to see if this approach can help when standard treatments have stopped working or aren’t an option.
This trial compares two types of radiation therapy (a newer technique called MH-ART versus a standard technique called CF-IMRT) given after surgery for cervical or endometrial cancer. The goal is to see which approach works better and causes fewer side effects.
Hear when a new Gynecologic Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.